Home › Funds › PAYDEN & RYGEL › ABBV

PAYDEN & RYGEL position in ABBV

ABBVIE INC · Health Care

PAYDEN & RYGEL reported holding 73,050 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$19.1M, representing 1.50% of its reported portfolio and ranking #19 among its reported holdings. PAYDEN & RYGEL has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)73.05K sh
Reported value held$19.11M
Portfolio Weight1.50%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PAYDEN & RYGEL's ABBV position evolved

PAYDEN & RYGEL first disclosed a stake in ABBV in Q3 2023 at 5,010 shares (US$747K). The position peaked in Q3 2026 at 73,050 shares, worth US$19.1M. Across 13 filings, PAYDEN & RYGEL increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 73,050 shares valued at US$19.1M. Notable position changes include a 46273% increase in Q1 2025 (shares fell 11% over the following quarter), a 100% trim in Q2 2025 (shares rose 26% over the following quarter), a 52091% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.01K $747.00K New
Q4 2023 5.01K $776.00K Hold
Q1 2024 5.01K $912.00K Hold
Q2 2024 5.01K $859.00K Hold
Q3 2024 5.01K $989.00K Hold
Q4 2024 110 $20.00K Reduce
Q1 2025 51.01K $10.69M Add
Q2 2025 110 $20.00K Reduce
Q3 2025 57.41K $13.29M Add
Q4 2025 57.01K $13.03M Reduce
Q1 2026 72.73K $15.82M Add
Q2 2026 73.25K $18.43M Add
Q3 2026 73.05K $19.11M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has PAYDEN & RYGEL held ABBV?

PAYDEN & RYGEL has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PAYDEN & RYGEL's current position in ABBV?

As of Q3 2026, PAYDEN & RYGEL holds 73.05K shares of ABBV (ABBVIE INC), valued at $19.11M, representing 1.50% of its reported portfolio and ranking #19.

Has PAYDEN & RYGEL been buying or selling ABBV?

In the latest 13F filing (Q3 2026), PAYDEN & RYGEL held unchanged its position in ABBV. The position peaked in Q3 2026 at 73.05K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.